Empera Meditech Private Limited
About Empera Meditech Private Limited
Data last updated:
Empera Meditech Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 06 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U85310TZ2018PTC029980. Its GSTIN is 33AAECE9253G1ZO (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Senthil Kumar Muthu Gounder and Gayathiri Ponnusamy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block – 2/1D Coral Castle Apartment Avinashi Road, Coimbatore, Tamil Nadu, India – 641004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.32 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹17.45 Lakh (net margin 13.2%) and EBITDA of ₹33.33 Lakh (EBITDA margin 25.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹35 Lakh on record.
Company details
Contact details
Empera Meditech Private Limited's registered office is in Coimbatore, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressBlock – 2/1D Coral Castle Apartment Avinashi Road, Coimbatore, Tamil Nadu, India – 641004
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Empera Meditech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Empera Meditech is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Empera Meditech Private Limited, buy the company report.
Financials of Empera Meditech Private Limited
FY 2025 filings availableEmpera Meditech Private Limited reported revenue of ₹1.32 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 26% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.2% | ||||
| Net Profit Margin | 13.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Empera Meditech Private Limited, buy the company report.
Board of directors of Empera Meditech Private Limited
Empera Meditech has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Senthil Kumar Muthu Gounder Also directs: Empera Industries India Private Limited, Quantas Bioscience Private Limited, Empera Health Service Private Limited and 2 more | Director | 04 Jun 2025 | 1 Years 5 Months | Current |
| Gayathiri Ponnusamy Also directs: Empera Industries India Private Limited, Quantas Bioscience Private Limited, Empera Health Service Private Limited and 2 more | Director | 06 Feb 2018 | 8 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2023 | 100752092 | Others | ₹20 Lakh | Open | |
| 21 Sep 2021 | 100489615 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Empera Meditech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Empera Meditech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Empera Meditech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECE9253G1ZO | Tamil Nadu | Active | 29 Mar 2018 |
To see the full GST registrations and return filing status of Empera Meditech Private Limited, buy the company report.
Recent activity
Empera Meditech Private Limited has 6 board changes on record since 2018: 3 appointments and 3 cessations. The latest: Senthil Kumar Muthu Gounder was appointed as Director on 04 Jun 2025.
Frequently asked questions
Empera Meditech is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 06 February 2018 (8+ years old) and is registered under CIN U85310TZ2018PTC029980.
Empera Meditech has 2 current directors:
- Senthil Kumar Muthu Gounder - Director
- Gayathiri Ponnusamy - Director
The latest financial statements of Empera Meditech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Empera Meditech is 33AAECE9253G1ZO, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Empera Meditech is U85310TZ2018PTC029980. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Empera Meditech was incorporated on 06 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Coimbatore.
Senthil Kumar Muthu Gounder was appointed as Director on 04 Jun 2025. Subburaj Mamitha ceased to be Additional Director on 29 Sep 2024. Subburaj Mamitha was appointed as Director on 05 Dec 2023. Empera Meditech has 6 board changes on record in total.
The registered office of Empera Meditech is at Block – 21D Coral Castle Apartment Avinashi Road, Coimbatore, Tamil Nadu, India – 641004.
Empera Meditech operates in the healthcare industry, in the preventive health services segment.
Empera Meditech has open charges of ₹35 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
